Merck | MRK - Net Income


Merck reported EUR450M in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
Adidas EUR 706M 351M Sep/2026
Adyen EUR 544.06M 37.5M Jun/2026
Akzo Nobel EUR -178M 317M Sep/2026
Alcon AG USD 189M 28M Mar/2026
Amadeus IT EUR 381.8M 38.1M Sep/2026
Amarin USD -1.22M 6.51M Dec/2025
AstraZeneca USD 3.12B 610M Sep/2026
BASF EUR 155M 3.99B Sep/2026
Bayer EUR -672M 891M Sep/2026
Beiersdorf EUR 551M 164M Jun/2026
Covestro EUR -378M 331M Dec/2025
Danone EUR 1.17B 388M Jun/2026
Fresenius EUR 371M 11M Sep/2026
Fresenius Medical Care EUR 160M 58.38M Sep/2026
Genmab DKK 303M 250M Jun/2026
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 1.54B 1.11B Sep/2026
GRIFOLS EUR 162M 8M Sep/2026
Henkel EUR 988M 63M Jun/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Infineon EUR 528M 109M Sep/2026
Lakefront Biotherapeutics EUR 2.11M 12.38M Jun/2026
Linde USD 1.69B 165M Sep/2026
Lonza CHF 426M 119M Jun/2025
Merck EUR 450M 40M Sep/2026
Novartis USD 1.2B 2.06B Sep/2026
Philips EUR 27M 357M Sep/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Sanofi EUR 3.02B 2.68B Sep/2026
UCB EUR 1.08B 608M Dec/2025